SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharma’s JV completes USFDA inspection at Gujarat facility

23 Sep 2019 Evaluate

Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies’ (Orbicular) Joint venture  -- Aleor Dermaceuticals (Aleor) has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with one observation. The inspection was carried out from September 16, 2019 to September 20, 2019.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

784.70 -0.95 (-0.12%)
07-May-2026 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1842.50
Dr. Reddys Lab 1310.35
Cipla 1373.30
Zydus Lifesciences 941.40
Lupin 2465.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×